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Abstract
Background: Patients with serious chronic illnesses face increasingly complex care and are at risk of poor
experience due to a fragmented health system. Most current patient experience tools are not designed to address
the unique care aspects of this population and the few that exist are delivered too late in the disease trajectory and
are not administered longitudinally which makes them less useful across settings.
Methods: We developed a new tool designed to address these gaps. The 25 item scale was tested and refined
using randomly cross-validated exploratory and confirmatory factor analyses. Participants were not yet hospice
eligible but sick enough to receive benefits of a supportive care approach in the last 2 to 3 years of life. Full
information maximum likelihood models were run to confirm the factor structure developed in exploratory
analyses. Goodness-of-fit was assessed with the Comparative Fit Index, the Tucker-Lewis Index, and the Root Mean
Square Error of Approximation. Test-retest reliability was assessed with the intraclass correlation coefficient and
internal consistency of the final scale was examined using Cronbach’s alpha.
Results: Exploratory factor analysis revealed three domains — Care Team, Communication, and Care Goals — after
removing weak loading and cross loading items. The initial three domain measurement model suggested in the
development cohort was tested in the validation cohort and exhibited poor fit X2 (206) = 565.37, p < 0.001; CFI = 0.879;
TLI = 0.864; RMSEA = 0.076. After model respecification, including removing one additional item and allowing paths
between theoretically plausible error terms, the final 21 item tool exhibited good fit X2 (173) = 295.63, p < 0.001;
CFI = 0.958; TLI = 0.949; RMSEA = 0.048. Cronbach’s alpha revealed high reliability of each domain (Care Team= 0.92,
Communication = 0.83, Care Goals = 0.77) and the entire scale (α = 0.91). ICC showed adequate test-retest validity
(ICC = 0.58; 95% CI: 0.52–0.65) of the full scale.
Conclusions: When administered earlier in the chronic illness trajectory, a new patient experience scale focused on
care teams across settings, communication, and care goals, displayed strong reliability and performed well
psychometrically.
Trial registrations: This trial (NCT01746446) was registered at ClinicalTrials.gov on November 27, 2012 (retrospectively
registered).
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Background
The Commonwealth Fund has stated that health care ex-
penditures in the United States (U.S.) are far higher than
those of other developed countries yet our results are not
better [1]. Berwick et al. laid the political foundations for
improving upon the U.S. health care system through the
pursuit of three aims — commonly referred to as the Triple
Aim [2] of: improving the experience of care, improving
the health of populations, and reducing costs. With the
signing of the Affordable Care Act (ACA) in the fall of
2010 [3], health systems in the U.S. are now incentivized to
deliver improved patient experience by the Centers for
Medicare & Medicaid Services (CMS) through its value-
based purchasing program [4]. As the single largest payer
for health care in the U.S., CMS is positioned well to drive
change nationally. Penalties went into effect in the fall of
2012 for inpatients and will go into effect on all CMS pa-
tients by 2018. Health systems in the U.S. are faced with a
need to improve the care experience for their patients. In
order to do so, providers must be able to track and under-
stand the experiences of some of their most frequent users
— patients with serious chronic illness. These patients must
manage ongoing chronic diseases while also facing frequent
acute care and challenges at the end of life. They are also at
risk for an overmedicalized, burdensome, and depersona-
lized experience [5, 6]. If patient experience is truly valued,
it is these patients who may require the most attention.
Patient experience is a standard health care measure,
payment criterion, and pillar in the Triple Aim [2, 7].
Current industry standard patient experience tools de-
ployed in the U.S., that are mandated by the ACA [4, 7, 8],
such as general and setting-specific variations of the Con-
sumer Assessment of Healthcare Providers and Systems
(CAHPS; e.g., for hospitals, clinics, or hospice) focus on
doctor-patient communication, access to care, and overall
ratings of experience [9–11]. These tools largely ignore
the broader context of care delivery via teams, and are not
particularly useful in understanding the experiences of pa-
tients with serious chronic illness, as they encounter care
across settings, health declines, and life transitions [12].
Many surveys of patient experience exist outside of the
U.S. [13] but few focus on patients with serious illness, fa-
voring a generalized approach to measurement. In
England, the National Health Service has been collecting
data on patients’ experience for over a decade [14]. Yet, to
our knowledge, no national health survey tailored to pa-
tients with serious chronic illness exists in England. How-
ever, some countries are developing tools tailored to more
advanced patient populations. The Ontario Hospital Asso-
ciation is developing a longitudinal patient experience tool
designed to capture a wide set of experience measures for
the complex continuing care sector [15]. Of the few tools
that do exist for patients with serious illness, many have
limitations.
Primarily, experience tools oriented toward palliative
care or end-of-life populations are often delivered too late
in the serious illness trajectory. Often the focus is within
the last 6 months of life or post hoc instruments of the be-
reaved [11, 16, 17]. Many tools do not ask patients about
medical and non-medical goals of care, care team relation-
ships versus communication, or whether patients feel the
care team understands the whole individual versus solely
aspects of patients’ physical wellbeing.
To address these gaps, our objective was to develop a
new patient experience measurement tool for individuals
with serious chronic illness that could be administered
longitudinally, as part of a larger health care delivery
intervention, and evaluate its psychometric properties.
Methods
Study design and context
This is an observational study aimed at developing and
validating a novel experience tool for individuals with
serious chronic illness in later life. It is part of a larger
evaluation of LifeCourse, a late-life care intervention,
which enrolled patients from October 2012 to July 2016
at a large, not-for-profit, integrated health system in the
upper Midwest. Allina Health has 13 hospitals, 84 pri-
mary care and hospital-based clinics, 15 retail pharmacy
sites, and 2 ambulatory care centers throughout Minne-
sota and western Wisconsin. Patients were recruited
after encounters at hospitals or clinics geographically
centered in Minneapolis and Saint Paul, Minnesota or
one of the nearby suburbs. Surveys were administered to
patients quarterly beginning on the enrollment date and
continuing until death or loss to follow-up.
Scale development
We developed the scale in stages between May and
September 2012. First, we conducted listening sessions or-
ganized by Twin Cities Public Television (TPT). Partici-
pants included stakeholders ranging from patients living
with a life limiting illness and their key family and friends
to clinicians and research team members. TPT recruited
participants to discuss their experience with late life care
as part of a planned documentary series on late life in
Minnesota, http://www.tpt.org/late-life/. The sessions
were filmed by TPT and facilitated by a marriage and fam-
ily therapist who is also a research scientist on the team.
Sessions were edited by TPT and then transcribed to in-
form intervention development. A workgroup of experts
was convened including clinicians in palliative care and
hospice and researchers in the areas of long-term care and
aging, patient-centered outcomes, team-based interven-
tions, and practice-based evaluation. They were primarily
tasked with intervention design during this stage. A sec-
ondary focus on learning more about the experience of
care for patients near the end of life emerged early on in
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the intervention design as one of many key outcomes to
be evaluated. This stage helped to inform the team what
matters most to patients and families.
Subsequently, a workgroup of clinicians and research
team members was formed to make critical decisions on
measurement of patient experience. The goal of the
workgroup was to evaluate the efficacy of current experi-
ence surveys and their applicability to both our interven-
tion design and patient population. We decided that the
intervention needed a general use scale appropriate for
our population that was agnostic of care setting and
could be deployed longitudinally to be useful in a broad
system-wide context. We then conducted a literature re-
view to evaluate existing measures. No measure was
found to be salient enough to our intervention or popu-
lation of interest so the group decided to develop its
own measure loosely based on the intervention’s guiding
principles but not designed to measure them directly.
Further, a patient and caregiver advisory council offered
insight to the study team. Qualitative findings were used
to help clarify the intervention’s guiding principles. The
final set of guiding principles—Know Me, Ask Me, Lis-
ten to Me, Hear Me, Guide Me, Respect Me, Comfort
Me, and Support Me—were used as a general framework
for deriving the survey’s domains and identifying associ-
ated survey items of potential interest.
Finally, candidate items found via literature review of
existing experience survey tools [10, 12, 18] in general
and as related to palliative care, hospice, and other set-
tings were reviewed in multidisciplinary team discussion
focused on comparing items to guiding principles and
LifeCourse intervention components (e.g., whole-person
care, patient goals). In several cases, existing tools did
not address LifeCourse’s guiding principles (e.g., ongoing
interpersonal relationships with care team), and so the
team crafted and reviewed its own items to address
those aspects. Existing scales were referenced for format-
ting, layout, and overall design elements but not for item
content. A candidate pool of 34 items was created and
selected by workgroup members. We conducted a pilot
study on 35 patients to informally evaluate the working
scale. Refinements were made by the workgroup based
on interviews with patients and feedback from trained
research interviewers who conducted surveys in person.
Redundant and confusing items were refined or removed
based on cognitive debrief interviews and a health liter-
acy assessment (REALM-R) of early versions of the tool
among pilot participants. Interviews and assessments fo-
cused on the applicability of specific word choice, re-
sponse options, and other issues [19]. Special attention
was paid to the survey length, survey formatting, and
ease of interpreting items due to the advanced age and
illnesses present in the majority of the sample. Calibri 14
point font was used to increase readability for visually
impaired participants and the tool scored 72.6 (7th
Grade) for Flesch Reading Ease and 5.9 for the Flesch-
Kincaid Grade Level.
Following our development process, the LifeCourse
experience tool tested in this paper included 25 items.
All items focused on experience associated with the par-
ticipants’ care team during the past 30 days and used a
four-point, frequency-based adjectival scale (1 = “Never”;
2 = “Sometimes”; 3 = “Usually”; 4 = “Always”), except for
items related to patients’ goals for their care, which used
a Likert scale with agreement-based responses (1
= “Strongly Disagree”; 2 = “Disagree”; 3 = “Agree”; 4
= “Strongly Agree”). The care team was purposefully de-
fined to be inclusive across care settings to reinforce a
whole system approach and included all members of
likely multiple care teams (e.g., physicians, nurses, aides,
care guides, social workers, chaplains, and others). Two
sets of items regarding experience during major transi-
tions and needing additional services or resources had
valid skip patterns (i.e., were structured missing) for in-
dividuals who did not have a transition or need add-
itional services. These items were not included in the
overall scale, though we did collect them for assessment
of the intervention. Additionally, we did not include two
global questions (“Rate your care over the past 30 days.”,
“Rate your support over the past 30 days.”) in factor ana-
lyses due to their high correlations with nearly all do-
mains and items. These two items were instead used in
tests of construct validity with the overall scale.
Participants
For this paper, we included a total of 903 enrolled pa-
tients in the analysis. Patients were identified as eligible
for intervention and comparison groups through the
combination of an electronic health record eligibility list
– which listed emergency department and inpatient
utilization in the prior year, advanced primary diagnosis
of heart failure, cancer, or dementia, and a validated co-
morbidity index [20]. The eligibility list risk stratified pa-
tients based on their comorbidity score. For patients
with dementia there was no comorbidity cutoff. For all
other patients a comorbidity score of 4 or greater was
required. A confirmative chart review was conducted by
an experienced registered nurse. Selected patients were
not yet hospice-eligible but sick enough to receive bene-
fits of a supportive care approach 2 to 3 years prior to
death. Detailed information about hospice eligibility cri-
teria used can be found in Additional file 1. Also, 35 pa-
tients were excluded for this study because they had
received an early pilot version of the LifeCourse experi-
ence tool. We excluded 261 patients who had completed
fewer than 80% of items, leaving 607 patients with data
for subsequent analyses (Fig. 1).
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Analyses
While we designed the experience tool as a complete
scale, we also tested the usefulness of specific domains as
independent subscales. We examined internal consistency,
test-retest reliability, item correlations, and a random
split-half cross validation design using exploratory and
confirmatory factor analyses. We used baseline measures
for the factor analyses and baseline through 3-month re-
sponses to calculate intraclass correlation for test-retest
reliability of the scale. All analyses were conducted in
Stata/MP version 14.1 [21].
We used exploratory factor analysis (EFA) to identify a
measurement model in the development cohort and
then subsequently evaluated factors/domains using con-
firmatory factor analysis (CFA) in the validation cohort
[22]. EFA used principal factor estimation and oblique
(promax) rotation. We determined the optimal number
of factors using the Kaiser criterion (i.e., eigenvalues > 1)
and a scree plot [23]. In a scree plot, eigenvalues are
plotted in descending value. The last substantial drop
was present between an eigenvalue of 3 and 4 prior to
flattening out suggesting we retain 3 factors [24]. Both
the Kaiser criterion and the scree plot suggested we
choose a 3 factor model.
We conducted CFA of the experience subscales using
full information maximum likelihood [25, 26]. Factor load-
ings from the EFA that were higher than 0.35 were freely
estimated while the rest were fixed at 0. Correlations
between latent factors were freely estimated as well, and
only the ones that significantly improved the fit of the
model and that were statistically significant were retained.
Model goodness of fit was evaluated using fit indices avail-
able in Stata, including the comparative fit index (CFI),
the Tucker-Lewis index (TLI), and the root mean square
error of approximation (RMSEA) [27].
We used Cronbach’s alpha to assess individual domain
and overall scale internal reliabilities of the final scale
with 0.80 considered as sufficient internal reliability. The
intraclass correlation coefficient (ICC) was calculated on
the total score using an unadjusted mixed-effects linear
model on a subsample of 360 participants’ baseline and
3 month measurement to assess test-retest reliability. To
assess general construct validity, we correlated the over-
all score with two global items asking patients to “Rate
your care” and “Rate your support”.
Results
Analytic sample
On average, respondents were aged 74 years, 50% were
female, and had 5 comorbidities. The majority of the re-
spondents were living at home with a primary diagnosis
of advanced heart failure. Participants had 5 inpatient
days, 2 emergency department visits, and 1 intensive
care unit stay in the 12 months prior to selection. The
randomly split development and validation cohorts had
304 and 303 cases, respectively. Patient characteristics
Fig. 1 Patient eligibility screening, enrollment, and analysis flow
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were not found to be statistically different between the
development and validation samples (Table 1).
Exploratory factor analysis
The EFA suggested a 3-factor model which accounted
for 92% of the total item variances (63%, 16%, and 13%).
Item 30, “My problem or physical symptom was well
controlled”, and item 9, “I received conflicting advice
from members of my care team”, were removed since
they did not load ≥0.35. Additionally, item 32, “I was
frustrated by the care I received”, cross-loaded on two
factors and was removed. We extracted three subscales
from the 22 remaining items: Care Team (14 items);
Communication (5 items); and Care Goals (3 items). For
all factors, we found good loadings for almost all items;
all loadings were between 0.40 and 0.84 (and most above
0.50). Items with rotated factor loadings of the domains
can be found in Table 2.
Confirmatory factor analysis
The 3-factor model from the EFA in the development
cohort was used as the initial measurement model for
the CFA and tested in the validation cohort. The initial
model exhibited poor fit X2 (206) = 565.37, p < 0.001;
CFI = 0.879; TLI = 0.864; RMSEA = 0.076. To address the
lack of fit, we explored model respecification as an itera-
tive process using a combination of the modification in-
dices (MI), expected parameter change (EPC), and
theoretical plausibility. Goodness-of-fit statistics after
each respecification can be found in Table 3.
After examining the model coefficients we discovered
item 4, “The care team relied upon my ideas to manage
my care”, did not load ≥ 0.35. This item exhibited weak
loadings in both the development and validation cohort,
possibly indicating it is associated with another unmeas-
ured factor so it was removed from analysis. Subse-
quently, all estimated coefficients in the model indicated
that the parameters from all three latent variables to
each of their items were all statistically significant with
fair to strong loadings (0.50–0.86), indicating that the
items related to their factors.
MI and EPC suggested that there were relationships
among some of the residuals between items within fac-
tors. After closely examining the items, we allowed
Table 1 Sample description overall and by cohort
Characteristic Overall (N = 607) Development Cohort (N = 304) Validation Cohort (N = 303) P-Valuea
N Mean ± SD/% N Mean ± SD/% N Mean ± SD/%
Age, years 607 74 ± 13 304 74 ± 12 303 74 ± 13 0.915
Comorbidity Scoreb 564 5 ± 2 280 5 ± 2 284 5 ± 2 0.745
Utilizationc
ED Visits 607 2 ± 2 304 2 ± 2 303 2 ± 3 0.963
Inpatient Days 607 5 ± 6 304 4 ± 6 303 5 ± 6 0.926
ICU Days 607 1 ± 3 304 0 ± 3 303 1 ± 4 0.285
Male 306 50% 149 49% 157 52% 0.490
Married or Living with Partner 286 47% 140 46% 146 48% 0.599
Caucasian 576 95% 291 96% 285 94% 0.352
Highest Level of Education 0.232
Non-Graduate, H.S. or GED 189 31% 99 33% 90 30%
Some College to 4-year Graduate 283 47% 148 49% 135 45%
Graduate or Professional School 123 20% 52 17% 71 23%
Unknown 12 2% 5 2% 7 2%
Participant Location at Baseline 0.539
Home 528 87% 269 88% 259 85%
Assisted Living 58 10% 26 9% 32 11%
Nursing Home 21 3% 9 3% 12 4%
Primary Diagnosis 0.485
Heart Failure 426 70% 220 72% 206 68%
Cancer 118 19% 54 18% 64 21%
Dementia 63 10% 30 10% 33 11%
aChi-square tests were used for categorical variables and two-sample t-tests for continuous variables
b43 participants were missing a baseline comorbidity score
cHealth care utilization measures were estimated in the 12 months prior to selection
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theoretically plausible correlations between some of the
residuals within the scale, which improved model fit.
These correlations were based on method effects which
we grouped into categories: (1) items which share similar
wording and adjacent to each other on the question-
naire, (2) care team related items which address access
to care, and (3) care team related items which address
care delivery. Error terms for these items were allowed
to be freely estimated and each model improved the fit
significantly (Table 3).
Factor loadings, factor labels, and correlations among
factors for the final model are presented in Fig. 2. The
final model exhibited good fit as evidenced by the Chi-
square/df ratio (1.71) below 2; X2 (173) = 295.63, p < 0.001;
CFI = 0.958; TLI = 0.949; RMSEA = 0.048. Weak to mod-
erate intercorrelations between domains were present.
The correlation between Care Team and Communication
was 0.61, Care Team and Care Goals was 0.45, and Com-
munication and Care Goals was 0.25.
Internal reliabilities were checked by calculating Cron-
bach’s alpha for each domain and the entire scale (Care
Team = 0.92, Communication = 0.83, Care Goals = 0.77,
LifeCourse Experience Scale = 0.91). Test-retest reliabil-
ity for the LifeCourse experience scale was measured
among participants surveyed at baseline and 3 months
(ICC = 0.58; 95% CI: 0.52–0.65). Since our experience
tool is designed to be deployed longitudinally, a high
test-retest reliability is not desirable for quarterly
Table 2 Rotated factor loadings from exploratory factor analysis in the development cohort (N = 304)
Items Factor 1 Factor 2 Factor 3
Chronbach’s Alpha 0.897 0.811 0.821
The care team helped me make a choice about my care when I had one. (Q12) 0.742 −0.029 0.056
The care team kept my wishes at the center of my care. (Q14) 0.737 0.012 −0.025
The care team helped me understand all of my options when I had a choice about my care. (Q11) 0.722 0.070 0.025
The care team respected me. (Q13) 0.709 0.010 −0.073
The care team helped me understand what was important to me. (Q10) 0.676 −0.038 0.075
I trusted my care team. (Q33) 0.650 0.015 −0.054
The care team helped me determine which providers I needed to see. (Q15) 0.634 −0.113 −0.008
The care team spent the right amount of time with me. (Q17) 0.630 0.075 −0.034
I received easy to understand information from the care team in response to my questions. (Q8) 0.624 0.034 0.044
The care team did everything they could to help with my problem or physical symptom. (Q31) 0.613 0.042 0.076
I was able to get in touch with someone on my care team when needed. (Q18) 0.568 0.117 −0.102
I got appointments as soon as I needed them. (Q16) 0.463 −0.006 0.002
The care team knew my personal circumstances or situation. (Q5) 0.458 0.048 0.131
The care team relied upon my ideas to manage my care. (Q4) 0.403 −0.117 0.122
I had to repeat myself when telling the care team about my life. (Q3) −0.035 0.750 0.033
I had to repeat myself when telling the care team about my medical condition. (Q1) −0.018 0.712 −0.054
I had to repeat myself when telling the care team about what was important to me. (Q2) 0.137 0.702 −0.081
I had unanswered questions about how my illness affected my everyday life. (Q7) −0.017 0.671 0.074
I had unanswered questions about how my illness affected my health. (Q6) −0.050 0.649 0.051
I have good understanding of my goals of care. (Q28) 0.003 0.062 0.841
I know what I need to do as part of my goals of care. (Q29) 0.013 0.012 0.807
My goals of care include what is important to me. (Q27) 0.051 −0.044 0.648
Table 3 Fit indices for each model tested during confirmatory factor analysis in the validation cohort (N = 303)
Modeling Step X2 df P CFI TLI RMSEA
1. Initial model suggested by EFA 565.372 206 <0.001 0.879 0.864 0.076
2. Removed item 4 for weak loading (0.33) 524.304 186 <0.001 0.884 0.869 0.077
3. Added path between error terms for items with similar wording and adjacency 358.480 179 <0.001 0.939 0.928 0.058
4. Added path between error terms for care team items related to access 327.332 176 <0.001 0.948 0.938 0.053
5. Added path between error terms for care team items related to care delivery 295.626 173 <0.001 0.958 0.949 0.048
EFA Exploratory Factor Analysis, CFI Comparative Fit Index, TLI Tucker - Lewis Index, RMSEA Root Mean Square Error of Approximation
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intervals as it would limit the ability of a tool adminis-
tered at multiple time points to detect change. Construct
validity was measured through correlating the Life-
Course Experience Scale with two global items which
asked participants to “Rate your care” and “Rate your
support” over the past 30 days. Both items correlated
significantly with the scale, r = 0.65 and r = 0.64, respect-
ively. Since these items correlated highly with all do-
mains and nearly all items, they were used as indicators
for a broad gauge of the construct of patient care
experience.
Discussion
A newly developed patient experience scale demon-
strated high reliability and validity and could be used in
further evaluation of care delivery experiences for those
late in life. Experience tools oriented toward existing
relationships and later-life care for complex patients
may allow for meaningful assessment and better under-
standing of targets for integrating and streamlining care.
This is especially important since existing patient-
centered tools, such as decision aids, do not guarantee
that patients will be treated as partners or that providers
will understand their wishes in late life [28, 29]. New
models of care, regardless of their design, require track-
ing and assessment with regard to their impact on rela-
tionships and communication with care teams and
whether patients’ goals are actively understood. This is
particularly true in later life. As patients age, their health
needs increase exceeding their individual capacity [30].
Several strengths in the design of this scale improve
measurement of patient experience in patients with
chronic life-limiting illnesses. First, our scale asks about



































































Fig. 2 Final confirmatory factor analysis (CFA) model of the LifeCourse patient experience tool (n = 303)
Fernstrom et al. BMC Palliative Care  (2016) 15:99 Page 7 of 10
experience scales which focus on doctor or nurse-only
experience. As health systems restructure toward new
care delivery models oriented on team-based care, focus
on evaluating teams is increasingly important. The care
team domain we designed also seeks to address interper-
sonal aspects of experiences between patients and care
teams. Second, our tool was designed to be implemented
across settings with a broad focus and targets patients
earlier in the chronic illness trajectory than existing
scales. For patients frequently experiencing complex
health care interactions in siloed health system divisions,
this is perhaps a more realistic reflection of what pa-
tients experience. Finally, our scale assesses patients’
goals of care. In a time of increasingly difficult care deci-
sions which often carry heavy consequences for patients
and their families, health systems need to focus more on
patient-defined medical and non-medical goals in their
efforts to improve care.
The usefulness of this tool may also be understood
within a global context in which chronic and non-
communicable diseases account for nearly 90% of deaths
in high-income countries (and increasing to nearly 70%
worldwide by 2030) [31]. Work on multimorbidity and pa-
tient burden in chronic conditions such as heart failure in
Europe, including guidelines on multimorbidity and meas-
urement of treatment burden [6, 32–34], reflects recogni-
tion of the patient-facing side of this reality. In such a
context, understanding how to address individuals’ needs
via integrated and holistic palliative care services is vital,
yet one review found only 20 countries to have advanced
levels of palliative care integration (about a third of coun-
tries worldwide had no known hospice or palliative care
activity) [35]. Among countries working toward palliative
care integration, standardization and an evidence base de-
rived from rigorous, patient-centered assessment remain
the focus of existing frameworks and calls for further work
[36–38]. In this context, we believe that an experience tool
for patients with serious chronic conditions in later life
may help to form such an evidence base to help drive
practice standards and improve care.
Limitations
This study has several limitations. Factor loadings could
be artificially inflated due in part to either the similarity
in item wording, likeness of the topic, and/or the adja-
cency of items concerning the same topic in the survey.
However, the fact that items with disparate wording also
loaded together on the same factors (e.g., in the Com-
munication domain) suggests that the underlying con-
structs were relatively cohesive across item content.
Correlated error terms could be indicative of underlying
undefined factors in the Care Team and Communication
domains or due to simple design effects such as cluster-
ing of questions about similar topics on the survey. Item
and questionnaire refinement focused on care team ac-
cess and the practical and interpersonal aspects of care
delivery, followed by additional analyses, could address
this limitation. However, this would need to be balanced
against additional length in a survey of patients already
prone to high rates of missing data.
With regard to item and unit missingness, future work
should focus on the recall time frame — as a 30 day look-
back period may be too brief if patients, despite having
complex conditions, are not having frequent visits. Con-
versely, it is also possible that respondents who have had
multiple encounters of various quality over longer lookback
periods struggle to average their experience as a whole.
There is a limited amount of research about the ability of
patients to recall their previous experience and how it may
be affected by reference periods [39–41]. Alternative event-
based approaches, such as that used by H-CAHPS [10]
may address this issue. However, there are tools currently
in large scale use in U.S. clinic settings with longer lookback
periods, like the 12 month period used in the CG-CAHPS
[9, 42] tool, which may exacerbate recall issues.
Further, encounter-based assessment may sacrifice re-
lational aspects of experience regarding care teams. The
CAHPS suite of tools assume a lot about the patient-
provider and patient-team relationship that is unlikely to
fit patients who see a lot of providers and overlooks the
team-based approach entirely. H-CAHPS and hospice
CAHPS [11] are event driven and hospice CAHPS is
sent to caregivers after the patient has died, so the mea-
sures don’t capture the patient’s overall, ongoing rela-
tionship with a team across a number of settings and
events like our tool. In addition, CAHPS experience
tools administered in older populations also suffer from
lower response rates [43, 44]. Additional validity studies
in different samples drawn at different times are needed
to ensure consistency of the results reported here. Fur-
thermore, our sample may not be representative of the
population at large and should be replicated in samples
with more diverse demographic profiles.
Missing data were somewhat problematic in our sample
— a common issue with survey burden in studies of pa-
tients with advanced illness [45, 46]. We addressed this in
analyses in two ways. First, patients with <80% response
(i.e., ≥5 missing items out of 25 total items) were dropped
from the analysis. Second, we used maximum likelihood
with the expectation-maximization (EM) algorithm to esti-
mate the covariance matrix [47], the EM covariance matrix
was used to obtain a factor solution. A factor loading cutoff
of 0.35 was used for low loadings or cross-loadings (cases
with high loading on more than one factor) [48].
Conclusions
With its focus on care teams, communication, and care
goals for patients with serious chronic illness, our new
Fernstrom et al. BMC Palliative Care  (2016) 15:99 Page 8 of 10
experience tool and its subscales, display strong reliabil-
ity and perform well psychometrically. This LifeCourse
experience tool, while developed as part of an interven-
tion study, may prove highly useful in describing and
studying patient experience across this and other popu-
lations, helping to further establish experience as a core
component of care quality and value for all patients
served by healthcare.
Additional file
Additional file 1: Eligibility criteria for hospice. (PDF 53 kb)
Abbreviations
ACA: Affordable Care Act; CAHPS: Consumer Assessment of Healthcare
Providers and Systems; CFA: Confirmatory factor analysis; CFI: Comparative fit
index; CMS: Centers for Medicare & Medicaid Services; EFA: Exploratory factor
analysis; EM: Expectation-maximization; EPC: Expected parameter change;
MI: Modification index; RMSEA: Root mean square error of approximation;
TLI: Tucker-Lewis index; TPT: Twin Cities Public Television
Acknowledgements
The authors would like to thank Cindy Cain, Allison Shipley, and Tetyana
Shippee for their substantial contributions to the direction of analysis, survey
design, and survey administration.
Funding
This study was funded by the Robina Foundation. The funding body had no
role in the study design, data collection, analysis, interpretation of data, and
writing of the manuscript.
Availability of data and material
Supplementary files for this manuscript including: (1) the data set, from
which personal identifiers of the participants were excluded; (2) the
questionnaire to collect information about participants developed for the
purpose of this study; are available from the corresponding author on
reasonable request.
Authors’ contributions
KF designed the study, conducted data analysis and interpretation, and
drafted the manuscript. NS designed the study, interpreted the data, and
commented on the final draft of the paper. AJ designed the study,
conducted data collection, and commented on the final draft of the paper.
HB conceived and designed the study and commented on the final draft of
the paper. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study was approved by Quorum institutional review board under the
protocol number 28142/1. Signed informed consent to participate in the
study was provided by all participants or a legally authorized representative.
Author details
1Division of Applied Research, Allina Health, 2925 Chicago Avenue, Mail Stop
#10039, Minneapolis, MN 55407, USA. 2Division of Health Policy and
Management, University of Minnesota School of Public Health, 420 Delaware
St. SE, D375 Mayo MMC 729, Minneapolis, MN 55455, USA.
Received: 24 August 2016 Accepted: 1 December 2016
References
1. Davis K, Stremikis K, Schoen C, Squires D: Mirror, mirror on the wall, 2014
update: how the US health care system compares internationally. The
Commonwealth Fund. 2014;16: 1-31.
2. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost.
Health Aff. 2008;27(3):759–69.
3. Obama B: United States health care reform: progress to date and next steps.
JAMA. 2016;316(5):525-32.
4. Centers for Medicare; Medicaid Services, HHS. Medicare program; hospital
inpatient value-based purchasing program. Final rule. Fed Regist. 2011;
76(88):26490.
5. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A.
Improving chronic illness care: translating evidence into action. Health Aff.
2001;20(6):64–78.
6. Jani B, Blane D, Browne S, Montori V, May C, Shippee N, Mair FS. Identifying
treatment burden as an important concept for end of life care in those with
advanced heart failure. Curr Opin Supportive Palliative Care. 2013;7(1):3–7.
7. VanLare JM, Conway PH. Value-based purchasing — national programs to
move from volume to value. N Engl J Med. 2012;367(4):292–5.
8. Kahn CN, Ault T, Potetz L, Walke T, Chambers JH, Burch S. Assessing
Medicare’s hospital pay-for-performance programs and whether they are
achieving their goals. Health Aff. 2015;34(8):1281–8.
9. Dyer N, Sorra JS, Smith SA, Cleary PD, Hays RD. Psychometric properties of
the consumer assessment of healthcare providers and systems (CAHPS (R))
clinician and group adult visit survey. Med Care. 2012;50(Suppl):S28–34.
10. O’Malley AJ, Zaslavsky AM, Hays RD, Hepner KA, Keller S, Cleary PD.
Exploratory factor analyses of the CAHPS hospital pilot survey responses
across and within medical, surgical, and obstetric services. Health Serv Res.
2005;40(6 Pt 2):2078–95.
11. Price RA, Quigley DD, Bradley MA, Teno JM, Parast L, Elliott MN, Haas AC,
Stucky BD, Mingura BE, Lorenz K. Hospice experience of care survey. 2014.
12. Mularski RA, Dy SM, Shugarman LR, Wilkinson AM, Lynn L, Shekelle PG, Morton
SC, Sun VC, Hughes RG, Hilton LK, et al. A systematic review of measures of
end-of-life care and its outcomes. Health Serv Res. 2007;42(5):1848–70.
13. Garratt A. National and cross-national surveys of patient experiences:
Nasjonalt kunnskapssenter for helsetjenesten (Norwegian Knowledge Centre
for the Health Services). 2008.
14. Coulter A, Locock L, Ziebland S, Calabrese J. Collecting data on patient experience
is not enough: they must be used to improve care. BMJ. 2014;348(1):g2225.
15. Patient Experience Survey Instruments [http://www.oha.com/CurrentIssues/
keyinitiatives/PRPM/Pages/PatientExperienceSurveyInstruments.aspx].
Accessed 3 Nov 2016.
16. Claessen SJJ, Francke AL, Sixma HJ, de Veer AJE, Deliens L. Measuring
relatives’ perspectives on the quality of palliative care: the consumer quality
index palliative care. J Pain Symptom Manag. 2013;45(5):875–84.
17. Downey L, Curtis JR, Lafferty WE, Herting JR, Engelberg RA. The Quality of
Dying and Death Questionnaire (QODD): empirical domains and theoretical
perspectives. J Pain Symptom Manag. 2010;39(1):9–22.
18. Coleman EA, Mahoney E, Parry C. Assessing the quality of preparation for
posthospital care from the patient’s perspective: the care transitions
measure. Med Care. 2005;43(3):246–55.
19. Bass 3rd PF, Wilson JF, Griffith CH. A shortened instrument for literacy
screening. J Gen Intern Med. 2003;18(12):1036–8.
20. Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined
comorbidity score predicted mortality in elderly patients better than
existing scores. J Clin Epidemiol. 2011;64(7):749–59.
21. StataCorp. Stata Statistical Software: Release 14. College Station: StataCorp
LP; 2015.
22. Gerbing DW, Hamiltion JG. Viability of exploratory factor analysis as a
precursor to confirmatory factor analysis. Struct Equ Model. 1996;3(1):62–72.
23. Kaiser HF. The varimax criterion for analytic rotation in factor analysis.
Psychometrika. 1958;23(3):187–200.
24. Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ. Evaluating the use of
exploratory factor analysis in psychological research. Psychol Methods. 1999;
4(3):272.
25. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete
data via the EM algorithm. Journal of the Royal Statistical Society Series B
(Methodological). 1977;39(1):1-38.
26. Enders CK, Bandalos DL. The relative performance of full information
maximum likelihood estimation for missing data in structural equation
models. Struct Equ Model. 2001;8(3):430–57.
Fernstrom et al. BMC Palliative Care  (2016) 15:99 Page 9 of 10
27. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure
analysis: conventional criteria versus new alternatives. Struct Equ Model.
1999;6(1):1–55.
28. Butler M, Ratner E, McCreedy E, Shippee N, Kane RL. Decision aids for
advance care planning: an overview of the state of the science. Ann Intern
Med. 2014;161(6):408–18.
29. Tiedje K, Shippee ND, Johnson AM, Flynn PM, Finnie DM, Liesinger JT, May
CR, Olson ME, Ridgeway JL, Shah ND. ‘They leave at least believing they had
a part in the discussion’: understanding decision aid use and patient-
clinician decision-making through qualitative research. Patient Educ Couns.
2013;93(1):86–94.
30. Shippee ND, Shah N, May CR, Mair F, Montori VM. Cumulative complexity: a
functional, patient-centered model of patient complexity can improve
research and practice. J Clin Epidemiol. 2012;65(10):1041–51.
31. Mathers C, Fat DM, Boerma JT. The global burden of disease: 2004 update.
Geneva: World Health Organization; 2008.
32. Farmer C, Fenu E, O’Flynn N, Guthrie B. Clinical assessment and
management of multimorbidity: summary of NICE guidance. BMJ. 2016;354:
i4843.
33. Gallacher K, May CR, Montori VM, Mair FS. Understanding patients’
experiences of treatment burden in chronic heart failure using
normalization process theory. Ann Fam Med. 2011;9(3):235–43.
34. Tran V-T, Harrington M, Montori VM, Barnes C, Wicks P, Ravaud P.
Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in
English using an internet platform. BMC Med. 2014;12(1):109.
35. Lynch T, Connor S, Clark D. Mapping levels of palliative care development: a
global update. J Pain Symptom Manag. 2013;45(6):1094–106.
36. Ahmedzai SH, Costa A, Blengini C, Bosch A, Sanz-Ortiz J, Ventafridda V,
Verhagen SC. A new international framework for palliative care. Eur J
Cancer. 2004;40(15):2192–200.
37. Garralda-Domezain E, Hasselaar J, Carrasco-Gimeno JM, Van Beek K, Siouta
N, Csikos A, Menten J, Centeno-Cortes C. Integrated palliative care in the
Spanish context: a systematic review of the literature. 2016.
38. Siouta N, van Beek K, Preston N, Hasselaar J, Hughes S, Payne S, Garralda E,
Centeno C, van der Eerden M, Groot M, et al. Towards integration of
palliative care in patients with chronic heart failure and chronic obstructive
pulmonary disease: a systematic literature review of European guidelines
and pathways. BMC Palliative Care. 2016;15(1):18.
39. Campbell J, Smith P, Nissen S, Bower P, Elliott M, Roland M. The GP patient
survey for use in primary care in the national health service in the UK-
development and psychometric characteristics. BMC Fam Pract. 2009;10:57.
40. Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR. Self-reports of
health care utilization compared to provider records. J Clin Epidemiol. 2001;
54(2):136–41.
41. Richards SH, Coast J, Peters TJ. Patient‐reported use of health service
resources compared with information from health providers. Health Soc
Care Community. 2003;11(6):510–8.
42. CG-CAHPS 12-Month Survey and Instructions [http://www.ahrq.gov/cahps/
surveys-guidance/cg/instructions/12monthsurvey.html]. Accessed 17 Nov
2016.
43. Zaslavsky AM, Zaborski LB, Cleary PD. Factors affecting response rates to the
consumer assessment of health plans study survey. Med Care. 2002;40(6):
485–99.
44. Elliott MN, Edwards C, Angeles J, Hambarsoomians K, Hays RD. Patterns of
unit and item nonresponse in the CAHPS hospital survey. Health Serv Res.
2005;40(6 Pt 2):2096–119.
45. Sprangers MA, Aaronson NK. The role of health care providers and
significant others in evaluating the quality of life of patients with chronic
disease: a review. J Clin Epidemiol. 1992;45(7):743–60.
46. McHorney CA, Ware Jr JE, Lu JF, Sherbourne CD. The MOS 36-item short-
form health survey (SF-36): III. Tests of data quality, scaling assumptions, and
reliability across diverse patient groups. Med Care. 1994;32(1):40–66.
47. Truxillo C. Maximum likelihood parameter estimation with incomplete data,
SAS Users Group: 04-10-2005 2005. Cary: SAS Institute Inc; 2005. p. 1–19.
48. Tabachnick BG, Fidell LS: Using Multivariate Statistics. Boston: Allyn and
Bacon; 2001.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Fernstrom et al. BMC Palliative Care  (2016) 15:99 Page 10 of 10
